Adma Biologics ADMA
NASDAQ ADMA
$9.72 -0.21 (-2.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Adma Biologics (ADMA) Selling, General & Administrative (2011 - 2026)

Updated

Adma Biologics' Selling, General & Administrative came in at $26.74 million for Q2 2026, up 20.4% from $22.21 million a year earlier and unchanged from the prior quarter.

Analysis

Adma Biologics (ADMA) Selling, General & Administrative (2011 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Adma Biologics reported Selling, General & Administrative of $98.77 million, up 12.0% year-over-year; for FY2025, it came in at $91.58 million, up 23.5% from FY2024.

  • Selling, General & Administrative has increased in each of the last ten years, with a five-year compound annual growth rate of 21.2% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $74.12 million in FY2024 (+25.6%), $59.02 million in FY2023 (+12.5%), $52.46 million in FY2022 (+22.3%) and $42.9 million in FY2021 (+22.4%).
  • The five-year range for quarterly Selling, General & Administrative is $10.73 million (Q3 2021) to $26.74 million (Q1 2026).
  • Year-over-year, Selling, General & Administrative has increased for 38 consecutive quarters, with growth averaging 26.7% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 0.8% (Q4 2025) to 54.0% (Q1 2025).
  • Business Quant data shows ADMA's Selling, General & Administrative at $26.74 million (Q1 2026), $23.51 million (Q4 2025) and $21.78 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Adma Biologics 2.24 Bn 1.81 Bn 86.28 Mn 26.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.74 Mn
Mar 31, 2026 26.74 Mn
Dec 31, 2025 23.51 Mn
Sep 30, 2025 21.78 Mn
Jun 30, 2025 22.21 Mn
Mar 31, 2025 24.08 Mn
Dec 31, 2024 23.32 Mn
Sep 30, 2024 18.56 Mn
Jun 30, 2024 16.61 Mn
Mar 31, 2024 15.64 Mn
Dec 31, 2023 15.54 Mn
Sep 30, 2023 14.73 Mn
Jun 30, 2023 14.25 Mn
Mar 31, 2023 14.51 Mn
Dec 31, 2022 13.89 Mn
Sep 30, 2022 12.89 Mn
Jun 30, 2022 11.97 Mn
Mar 31, 2022 13.70 Mn
Dec 31, 2021 11.70 Mn
Sep 30, 2021 10.73 Mn
API Access

Adma Biologics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ADMA&period=max&api_key=YOUR_API_KEY